No ownership or control links for LI XIAOYU are resolved in the current sources yet — view the network graph to expand, or pull the cited JSON dossier.

What is LI XIAOYU's risk level?

WhiteIntel flags LI XIAOYU as low risk. Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership.

Where does LI XIAOYU appear across sources?

LI XIAOYU is indexed in the WhiteIntel corporate-ownership graph (US), with a source on every claim.

LIVE · CORPUS

Dossier

■

LI XIAOYU

Name: LI XIAOYU — ownership dossier
Creator: WhiteIntel
License: https://whiteintel.dev/terms
Keywords: corporate ownership, beneficial ownership, UBO, corporate intelligence, OSINT, corporate registry, LI XIAOYU, Company, US

Low

CompanyUS

View network JSON / MCPsample

Fig. 01 — Cross-source signature

/01

At a glance

Dimensions on file

Subsidiaries: 2

/02

Key facts

Risk signal

Low

Risk

LI XIAOYU is a Company registered in US resolved across 1 source in the WhiteIntel corporate-ownership graph.

/03

Ownership & control

Owners / controllers

None in current sources.

Holdings / subsidiaries

LI XIAOYU
- ANPAC BIO-MEDICAL SCIENCE CO., LTD.· officer· via SEC EDGAR

/04

Directorship network

7 other roles

Where this entity’s officers also hold (or held) positions — the wider network reached through shared people. Roles are registry records, not a claim of control.

ANPAC BIO-MEDICAL SCIENCE CO., LTD.

XU HAOHANofficer
XU HAOHANtenpercentowner
LIANG ZHIJUNdirector
PU TIANRUOdirector
ZHAO ZHIGANGdirector
XU HAOHANdirector
TIAN HONGGANGdirector

/ Community notesFREE

Analyst context the registries don’t carry — corrections, links, open questions on LI XIAOYU. Notes are community-contributed leads, not verified facts.

Loading notes…